These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5524005)

  • 1. [Psychopharmaca in the treatment of paranoid-hallucinatory syndromes].
    Vucković S; Til E
    Neuropsihijatrija; 1970; 18(2):255-60. PubMed ID: 5524005
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the question of the paranoid-hallucinatory psychoses after typhus encephalitis].
    Bussopulos W
    Fortschr Neurol Psychiatr Grenzgeb; 1966 Jan; 34(1):39-43. PubMed ID: 5182353
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neuroleptic long term care with extremely low doses in psychotic syndromes of paranoid-hallucination type].
    Rossner M; König L
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():161-4. PubMed ID: 829614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroencephalographic investigations on the question of the initial state under neuroleptic therapy.
    Geyer N; Lechner H
    Electroencephalogr Clin Neurophysiol; 1967 Aug; 23(2):185. PubMed ID: 4166713
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the activity of 2 neuroleptics].
    Blanc M; Borenstein P; Brion S; Buisson JF; Debray HR; Digo R; Flavigny H; Follin S; Minvielle J; Morel-Maroger A; Pichot P; Rainaut J; Sutter JM
    Encephale; 1970; 59(2):97-161. PubMed ID: 5458713
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical treatment of chronic psychoses with flupenthixol-decanoate (Fluanxol-Depot)].
    Gross H; Kaltenbäck E
    Wien Klin Wochenschr; 1972 Feb; 84(5):80-4. PubMed ID: 5015880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of thiopropazate (Dartalan) in psychotic patients].
    Vencovský E; Peterová E; Baudis P; Dvoráková M
    Act Nerv Super (Praha); 1970 Jan; 12(1):59-60. PubMed ID: 5418660
    [No Abstract]   [Full Text] [Related]  

  • 8. [Psychopharmacotherapy and problems of delineating borderline forms of neuropsychic disorders].
    Aleksandrovskii IuA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(11):1713-7. PubMed ID: 4450901
    [No Abstract]   [Full Text] [Related]  

  • 9. [Information-statistical studies on the structure of simple response sequences in endogenous psychoses].
    Axmacher I; Bente D; Ferner U
    Arzneimittelforschung; 1970 Jul; 20(7):919-21. PubMed ID: 5536060
    [No Abstract]   [Full Text] [Related]  

  • 10. [Differential indication for the use of neuroleptics].
    Vinar O
    Act Nerv Super (Praha); 1970 Jan; 12(1):1-11. PubMed ID: 4907389
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ponsital in the clinical psychiatric practice].
    Vencovský E; Peterová E; Baudis P; Dvoráková M; Janovský F
    Act Nerv Super (Praha); 1970 Jan; 12(1):52-3. PubMed ID: 5418658
    [No Abstract]   [Full Text] [Related]  

  • 12. Thiothixene in the treatment of paranoid psychoses.
    Medvecký J; Safko S; Medvecká E
    Act Nerv Super (Praha); 1972; 14(2):92-3. PubMed ID: 5040179
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetophenazine for office treatment of paranoid symptoms.
    Cahan RB
    West Med Med J West; 1967; 8(3):71-2. PubMed ID: 6072166
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluspirilene in the treatment of chronic schizophrenic outpatients.
    St-Laurent J; Carle R; Domingue D
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):599-608. PubMed ID: 4628682
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trial of delayed-action neuroleptics in the treatment of acute psychotic conditions].
    Gayral L; Escande M; Fournié H; Perretti A
    Ann Med Psychol (Paris); 1972 Mar; 1(3):381-94. PubMed ID: 5053751
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proketazine in the treatment of psychotic syndromes].
    Klosińska B; Wierzbicki T
    Psychiatr Pol; 1967; 1(1):69-71. PubMed ID: 5597274
    [No Abstract]   [Full Text] [Related]  

  • 17. [EEG - changes in paranoid-hallucinatory psychoses treated with Clozapine].
    Isermann H; Haupt R
    Nervenarzt; 1976 Apr; 47(4):268. PubMed ID: 1272487
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the therapy of paranoid hallucinatory syndrome by a new neuroleptic mixture].
    DOEHNER W; ECKMANN F
    Med Klin; 1963 Jan; 58():24-5. PubMed ID: 14028326
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the effects of sulpiride on the mental state of 40 mental patients].
    Carrère J
    Ann Med Psychol (Paris); 1968 Nov; 2(4):560-74. PubMed ID: 5709615
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug therapy of paranoid psychoses].
    Robak OH
    Tidsskr Nor Laegeforen; 1978 Jun; 98(16):852-4. PubMed ID: 675631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.